Zhongzhi Pharmaceutical Holdings Limited

HK$0.67As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3737Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (5.10%)
Div yield —
ROE 1.63%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.38
PE TTM 27.40
TSR TTM 7.26%
Mkt cap HK$574.3M
ROIC 0.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.638
(4.07%)
(73.07%)
Hold 7|5|1|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
26.90%
17.23%
10.38%
6.43%
Revenue¥M
63.96
63.26
66.03
68.17
0.88%
(2.72%)
(0.97%)
3.47%
Peers (US$73.26M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.303
—
—
EBIT/Intx
1.943
0.037
0.040
Own earn%
59.53
(18.81)
(21.92)
Sh yield%
32.65
38.47
39.02
Owners
Insiders/Inst%
13.48
37.37
Short interest%
5.06
SBC / revenue%
3.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–7
$1 testx
−0.4
Incr. ROIC%
18